HUMACYTE, INC.
Bioengineered human tissues created from human cells using a scalable platform for implantation
- Sector
- Biotech
- Headquarters
- DURHAM, NC
- Latest Form D
- $150M, Jun 2018
- Total capital
- $226M
- Federal grants
- $968K
- 1 award · 2015
- Rank in peer group#18 of 18
- Private capital raised
- $225M
- 2 Form D · last Jun 2018
- 100 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 17 pending · first 2017
- Rank in peer group#2 of 18
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$150M
- Private capital raisedForm D · SEC · 1st filing$75M
- Federal grantHealth and Human S · Phase II · Novel Manufacturing Processes for Tissue Engineered Vascular Grafts$968K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
34months
from HUMACYTE, INC.’s first federal award to its first private round.
- First federal award · May 2015
- Health and Human S · $968K
- First Form D · Mar 2018
- $75M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 18 peers
Line = medianBiotech · Material
- Federal grantsBelow median
- Granted patents#2 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ted S. LithgowResearcherExecutive OfficerLinked by $968K in grants as PI
- Brady E. DouganDirectorNamed in SEC Form D filings
- Carrie S. CoxExecutive Officer, DirectorNamed in SEC Form D filings
- Dale A. SanderDirectorNamed in SEC Form D filings
- Jeffrey H. LawsonExecutive OfficerNamed in SEC Form D filings
- Kathleen A. SebeliusDirectorNamed in SEC Form D filings
Show all 14 people
- Laura E. NiklasonExecutive Officer, DirectorNamed in SEC Form D filings
- Matthew E. MegaroDirectorNamed in SEC Form D filings
- Max E. WallaceDirectorNamed in SEC Form D filings
- Paul A. BoyerExecutive OfficerNamed in SEC Form D filings
- Robert AndersonDirectorNamed in SEC Form D filings
- Robert W. LangerDirectorNamed in SEC Form D filings
- Theodore S. LithgowExecutive OfficerNamed in SEC Form D filings
- William H. TenteExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 9 granted of 26- PendingApparatus And Methods Of A Tubular Tissue As A Therapeutic Agent-producing Sheath For A Vascular GraftUSPTOApplication 18937529
- GrantedDrawer System For Cultivating TissueUSPTOUS 12,195,711
- GrantedSystem, Apparatuses, Devices And Methods For Straining A Cultivated TissueUSPTOUS 12,104,148
Show all 26 patent records
- Apparatus And Methods Of A Tubular Tissue As A Therapeutic Agent-producing Sheath For A Vascular GraftMay 1, 2025 · Application 18937529Pending
- Drawer System For Cultivating TissueJan 14, 2025 · US 12,195,711Granted
- System, Apparatuses, Devices And Methods For Straining A Cultivated TissueOct 1, 2024 · US 12,104,148Granted
- Fluid Systems, Apparatuses, Devices And Methods Of Management Thereof For Cultivating TissueApr 16, 2024 · US 11,959,060Granted
- Tissue-engineered ConstructsMar 16, 2021 · US 10,947,498Granted
- Tissue-engineered ConstructsMar 2, 2021 · US 10,934,522Granted
- Tissue-engineered ConstructsApr 14, 2020 · US 10,619,132Granted
- Methods And Apparatuses For Forming Fibrous TubesJul 30, 2019 · US 10,363,124Granted
- Tubular Tissue-engineered ConstructsMay 23, 2017 · US 9,657,265Granted
- Tissue-engineered ConstructsMay 18, 2017 · Application 15420901Pending
- Tissue-engineered ConstructsMay 16, 2017 · US 9,650,603Granted
- Compositions and Methods for Soft Tissue AugmentationDec 4, 2014 · Application 14461644Pending
- Apparatus And Methods Of A Tubular Tissue As A Therapeutic Agent-producing Sheath For A Vascular GraftApplication 63503137Pending
- Apparatus And Methods Of A Tubular Tissue As A Therapeutic Agent-producing Sheath For A Vascular GraftApplication PCTUS2023068296Pending
- Methods And Apparatuses For Forming Fibrous TubesApplication PCTUS2015051015Pending
- Methods And Apparatuses For Forming Fibrous TubesApplication 62052236Pending
- Apparatuses For Tissue And Organ Production And StorageApplication PCTUS2012041649Pending
- Elastin For Soft Tissue AugmentationApplication PCTUS2010035568Pending
- Tissue And Organ Graft Bioreactor And Method Of OperationApplication PCTUS2010029942Pending
- Systems, Devices And Methods For Engineered Tissue Construct Transport And ContainmentApplication PCTUS2020064598Pending
- Compositions And Methods For Soft Tissue AugmentationApplication PCTUS2008008970Pending
- Apparatus And Methods Of A Tubular Tissue As A Therapeutic Agent-producing Sheath For A Vascular GraftApplication 63351677Pending
- Devices And Methods Of A Medicament-producing Implantable MatrixApplication 63438444Pending
- Systems, Devices And Methods For Engineered Tissue Construct Transport And ContainmentApplication 62946645Pending
- Systems, Apparatuses, Devices And Methods For Straining A Cultivated TissueApplication 62849496Pending
- Drawer System For Cultivating TissueApplication 62849485Pending
Related companies, and why
- Turning Point TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Stylus MedicineSimilar federal contract value in Biotech · null in contracts
- HYKU BIOSCIENCES INC.Similar federal contract value in Biotech · null in contracts
- NEKTAR THERAPEUTICSSimilar federal contract value in Biotech · null in contracts
- Natglycan, LLCSimilar federal contract value in Biotech · null in contracts
- Tourmaline BioSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .